Bisphosphonate-related Femoral Shaft Fracture

Area of Science:

• Orthopedics
• Pharmacology
• Geriatrics

Background:

• Bisphosphonates are a cornerstone therapy for osteoporosis, effectively reducing fracture risk.
• Long-term bisphosphonate use is associated with potential adverse effects, including rare skeletal complications.
• Atypical subtrochanteric fractures are a growing concern in patients receiving bisphosphonate therapy.

Observation:

• This case report details patients experiencing non-traumatic or low-energy subtrochanteric fractures.
• These fracture patterns are atypical for the typical mechanisms of injury in osteoporotic patients.
• The patients in question were undergoing long-term bisphosphonate treatment.

Findings:

• A potential association exists between long-term bisphosphonate use and the occurrence of atypical subtrochanteric fractures.
• These fractures present with unusual characteristics and mechanisms of injury.
• The findings underscore a rare but significant side effect of bisphosphonate therapy.

Implications:

• Increased clinical awareness and suspicion for atypical subtrochanteric fractures in patients on bisphosphonates are warranted.
• This highlights the importance of balancing the benefits of bisphosphonate therapy against potential risks.
• Further research into the mechanisms and management of these fractures is crucial.